TEMPE, Ariz. – July 26, 2023 – BioCareSD is now a limited distributor of the U.S. Food & Drug Administration (FDA) approved therapy, ROCTAVIAN used to treat severe hemophilia A (congenital factor VIII...
The process of scaling your business can seem daunting, but with the right considerations and strategies, it can be navigated with confidence and efficiency. Here are seven tips to help you before, during and after your...
BioCareSD, a specialty distributor of life-saving therapies, is proud to announce the addition of LEQEMBI to their diverse portfolio of specialty therapeutics. LEQEMBI was recently approved by the U.S. Food and Drug Administration (FDA) under the...
BioCare, Inc., a leading specialty pharmaceutical distribution partner that provides distribution, specialty pharmacy, and logistics services, has been recognized by the Financial Times as one of “The Americas’ Fastest Growing Companies 2023.” The list, compiled by the...
BioCareSD announced its partnership with AllyRetina. Debuting at the American Society of Retina Specialists (ASRS) 24th Annual Business of Retina conference this week, AllyRetina will serve its GPO members through its physician leadership, a seasoned management team,...
BioCare, a leading specialty pharmaceutical distribution partner that provides distribution, specialty pharmacy, and logistics services, today announced that its Chief Information Officer (CIO), Cory Shouse, was selected by the ORBIE Awards committee...
The country is breathing a collective sigh of relief as a rail strike was narrowly avoided this past year. While we were able to steer clear of it this time, it got many people thinking about...
BioCare, Inc., specializing in delivering specialty and therapeutic biological products since 1982, has named two healthcare industry veterans to their leadership team. Healthcare sales executive Mike Collins was named Vice President of Sales for BioCareSD, the company's specialty...
BioCareSD, a specialty distributor of life-saving therapies, today announced that ALTUVIIIO [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl], previously referred to as efanesoctocog alfa, is now available through their network. It is indicated for routine prophylaxis and...
For the past two and a half years, organizations have had to learn to operate across remote and hybrid environments at an unprecedented rate. Initially, the issues that stemmed from immediate and widespread remote work were plentiful:...
